Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Maloney

Showing results (11-20 of 441) with videos related to

Pageof 45
Sort By:
Anti-Cancer Drugs|August 18, 2001
Mechanism of action of rituximabD G Maloney
Seminars in Oncology|March 24, 2005
Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targetsDavid G Maloney
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccinesDavid G Maloney
Hematology. American Society of Hematology. Education Program|November 21, 2007
Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effectsDavid G Maloney
Current Opinion in Hematology|September 25, 1998
Advances in immunotherapy of hematologic malignanciesD G Maloney
Oncology (Williston Park, N.Y.)|February 7, 2008
What is the role of maintenance rituximab in follicular NHL?David G Maloney
Hematology/Oncology Clinics of North America|June 27, 2021
Immune Therapy for Chronic Lymphocytic Leukemia: Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and BeyondMazyar Shadman, David G Maloney
Journal of Microbiological Methods|August 22, 2025
Sequencing on the edge: Tools and techniques for sequencing low biomass isolates from unicellular eukaryotic parasites and other challenging samplesKatherine Hshieh, Jenny G Maloney
Hematology/Oncology Clinics of North America|August 31, 2020
Allogeneic Transplantation and Chimeric Antigen Receptor-Engineered T-Cell Therapy for Relapsed or Refractory Mantle Cell LymphomaJordan Gauthier, David G Maloney
Cahiers Des Etudes Anciennes|January 1, 1976
[Not Available]G Maloney, W F Villeneuve
Pageof 45

Showing results (11-20 of 441) with videos related to

Sort By:
Pageof 45
Anti-Cancer Drugs|August 18, 2001
Mechanism of action of rituximabD G Maloney
Seminars in Oncology|March 24, 2005
Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targetsDavid G Maloney
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccinesDavid G Maloney
Hematology. American Society of Hematology. Education Program|November 21, 2007
Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effectsDavid G Maloney
Current Opinion in Hematology|September 25, 1998
Advances in immunotherapy of hematologic malignanciesD G Maloney
Oncology (Williston Park, N.Y.)|February 7, 2008
What is the role of maintenance rituximab in follicular NHL?David G Maloney
Hematology/Oncology Clinics of North America|June 27, 2021
Immune Therapy for Chronic Lymphocytic Leukemia: Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and BeyondMazyar Shadman, David G Maloney
Journal of Microbiological Methods|August 22, 2025
Sequencing on the edge: Tools and techniques for sequencing low biomass isolates from unicellular eukaryotic parasites and other challenging samplesKatherine Hshieh, Jenny G Maloney
Hematology/Oncology Clinics of North America|August 31, 2020
Allogeneic Transplantation and Chimeric Antigen Receptor-Engineered T-Cell Therapy for Relapsed or Refractory Mantle Cell LymphomaJordan Gauthier, David G Maloney
Cahiers Des Etudes Anciennes|January 1, 1976
[Not Available]G Maloney, W F Villeneuve
Pageof 45